CorMedix Inc.
CRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $477 | $191 | $169 | $171 |
| - Cash | $41 | $44 | $43 | $53 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $437 | $148 | $127 | $119 |
| Revenue | $43 | $0 | $0 | $0 |
| % Growth | – | -100% | -65.7% | – |
| Gross Profit | $40 | -$0 | $0 | $0 |
| % Margin | 92.7% | – | 94.3% | 22% |
| EBITDA | -$19 | -$46 | -$30 | -$29 |
| % Margin | -43.7% | – | -45,945.1% | -15,385.1% |
| Net Income | -$18 | -$46 | -$30 | -$28 |
| % Margin | -41.2% | – | -45,409.9% | -14,774.7% |
| EPS Diluted | -0.3 | -0.91 | -0.74 | -0.75 |
| % Growth | 67% | -23% | 1.3% | – |
| Operating Cash Flow | -$51 | -$38 | -$24 | -$21 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$51 | -$39 | -$25 | -$23 |